Home Sign In About Curriculum Activity Information Target Audience Learning Objectives Technical Requirements
The Curriculum in Iron Metabolism & Related Disorders is supported by an educational grant from
Novartis Oncology

Created in consultation with
Projects In Knowledge®, developers of certificate programs in medicine.

Projects In Knowledge is a registered trademark of Projects In Knowledge, Inc.

Course materials have been developed for use outside of the United States.
banner

  Learning Objectives  |   Posttest  |   Technical Requirements

Epidemiology and Disease Pathophysiology: Thalassaemia II



"Epidemiology and Prevention of Thalassaemia," by Androulla Eleftheriou, in: Eleftheriou A. About Thalassaemia, Nicosia, Cyprus: Thalassaemia International Federation, 2007, Chapter 12, pages 117-129, is reprinted here with permission. We wish to thank Dr. Eleftheriou, author, and the Thalassaemia International Federation, publisher.

Table of Contents

Epidemiology
Page 117
Prevention
Page 118
The Importance of Prevention
Page 119
How Thalaessaemia Is Inherited
Page 119
About Carriers of the Thalassaemia Trait
Page 120
Why It Is Important to Know If You Are a Carrier
Page 120
Other Abnormal Haemoglobins\Haemoglobin Disorders
Page 121
Finding Out Whether You Are a Carrier
Page 123
Who Should Have a Blood Test
Page 125
Consanguinity
Page 126
Choices Available for an "At-Risk" Couple
Page 126
Testing a Foetus for Thalassaemia
Page 127

Target Audience

This activity is designed for haematologists, medical oncologists, haematology-oncology specialists, paediatricians and other healthcare professionals involved in the screening, prevention, evaluation, testing, counseling, and management of adults and children who have or are at risk of developing B-thalassaemia or are B-thalassaemia carriers.

Learning Objectives

After participating in this activity, participants should be better able to:
  • Apply your knowledge of the epidemiology and genetic transmission pattern of B-thalassaemia to identify individuals at risk of transmitting the disease to their offspring and to encourage these individuals to be tested for the B-thalassaemia trait.
  • Utilize your knowledge of the pattern of genetic transmission of B-thalassaemia and the options available to at-risk individuals wishing to have children, in order to provide effective genetic counseling to B-thalassaemia patients, B-thalassaemia carriers, and their spouses.
  • Based on your knowledge of other abnormal haemoglobins/haemoglobin disorders, assess your at-risk patients and their spouses for the additional presence of other abnormal haemoglobins/haemoglobin disorders in order to counsel patients about the risk and clinical consequences of transmitting combined haemoglobin abnormalities to their offspring.

top


Download PDF

Posttest

 
ESH-Centre Hayem, Hôspital Saint-Louis, 1 avenue Claude Vellefaux, 75475 Paris Cedex 10, France - Contacts
All Rights Reserved - Copyright ESH 2010